Acute stent occlusion due to secondary thrombosis in a patient with romatoid arthritis

Yıl 2008, Cilt: 13 Sayı: 1-2, 38 - 42, 14.01.2013

Mustafa Tuncer Hasan Ali Gümrükcüoğlu Yılmaz Gunes Hakki Şimsek Musa Şahin Ünal Güntekin İmdat Dilek

Öz

Abstract. It has been known that rheumatoid arthritis is a risk factor for cardiovascular events. However, secondary thrombocytosis is not accepted as a risk factor for acute myocardial infarctus. We presented a case of acute myocardial infarction associated with secondary thrombocytosis. Primary percutaneous transluminal coronary angioplasty and stenting were performed due to acute myocardial infarction. Then, patient started to receive clopidogrel, aspirin, glycoprotein IIb/IIIa receptor blocker (trofiban) and standard heparin.  But, repeated coronary angiography was required due to stent thrombosis, because persistent chest pain and ST elevation at anterior leads were observed approximately 4-6 hours after primary percutaneous transluminal coronary angioplasty. Repeated angiograph revealed acute stent restenosis and then the revascularization was achieved by balloon angioplasty. 

 

Key words: Secondary thrombocytosis and acute myocardial infarctus

Anahtar Kelimeler

Secondary thrombocytosis and acute myocardial infarctus

Kaynakça

• 1. Lebovitz WB. The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two cases. Ann Intern Med 1963; 58: 102-123.
• 2. Knonkaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797- 804.
• 3. Del Rincon I,Williams K, SternMP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-2745.
• 4. Ertenli I, Kiraz S, Arici M, et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheum 1998; 25: 1054-1058.
• 5. Hahn BH, Grossman J, Chen W, et al. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007; 28: 69-75.
• 6. Hollen CW, Henthorn J, Koziol JA, et al. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991; 79: 286-290.
• 7. Saffitz JE, Phillips ER, Temesy-Armos, et al. Thrombocytosis and fatal coronary heart disease. Am J Cardiol 1983; 52: 651-652.
• 8. Pick RA, Glover MU, Nanfro JJ, et al. Acute myocardial infarction with essential thrombocythemia in a young man. Am Heart J 1983; 106: 406-407.
• 9. Koh KK, Cho SK, Kim SS, et al. Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis. Int J Cardiol 1993; 41: 168-170.
• 10. Alioglu E, Tuzun N, Sahin F, et al. Non STsegment elevation myocardial infarction in patient with essential thrombocythemia. Thromb J 2009; 20: 7: 1-5.
• 11. Spivak JL Polycythemia vera and other myeloproliferative diseases. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL and Longo DL as (eds). Harrison’s Principles of Internal Medicine. 14th edn. The McGraw-Hill Companies, Inc., New York, 1998 Vol. 1. pp. 683-684.
• 12. Mitus AJ, Schafer AI Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 1990; 4: 157-178.
• 13. McIntyre KJ, Hoagland HC, Silverstein MN, et al. Essential thrombocythemia in young adults. Mayo Clin Proc 1991; 66: 149-154.
• 14. Momiyama T, Hiranaka T, Nomura F, et al. Coronary artery bypass grafting for left main trunk coronary artery lesion associated with essential thrombocythemia. Clin Cardiol 1993; 16: 691-693.
• 15. Michaels AD, Whisenant B, MacGregor JS: Multivessel coronary thrombosis treated with abciximab in a patient with essential thrombocythemia. Clin Cardiol 1998; 21: 134-138.
• 16. Rossi C, Randi ML, Zerbinati P, RinaldiV, Girolami A.Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 1998; 244: 49-53.
• 17. Ozben B, Ekmekci A, Bugra Z, et al. Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis. J Thromb Thrombolysis 2006; 22: 79-84.